ESSA Pharma Stock Dips on Reduced Shareholder Benefits

ESSA Pharma Inc. shares are trading lower after the company amended its agreement with XenoTherapeutics, reducing expected shareholder payouts from the originally estimated $1.91 per share to approximately $0.12 per share, plus contingent value rights.